SOX17 and breast carcinoma: For instance, transcription factor SOX17 (SOX17), slit guidance ligand 3 (SLIT3), and cysteine dioxygenase type 1 (CDO1) that are frequently suppressed by hypermethylation in breast cancer [35, 36], turned hypomethylated after resveratrol treatment.